Allergic diseases in children in the age of the COVID-19 pandemic
COVID-19 coronavirus infection caused by the SARS-CoV-2 virus has become a real disaster for all of humanity. Today, issues related to diagnostics, clinical presentations, treatment of the complications, preventive measures, including vaccination for a new coronavirus infection, are relevant. It is...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ltd. “The National Academy of Pediatric Science and Innovation”
2023-01-01
|
| Series: | Rossijskij Vestnik Perinatologii i Pediatrii |
| Subjects: | |
| Online Access: | https://www.ped-perinatology.ru/jour/article/view/1738 |
| _version_ | 1797875114104061952 |
|---|---|
| author | Sh. A. Sulaimanov |
| author_facet | Sh. A. Sulaimanov |
| author_sort | Sh. A. Sulaimanov |
| collection | DOAJ |
| description | COVID-19 coronavirus infection caused by the SARS-CoV-2 virus has become a real disaster for all of humanity. Today, issues related to diagnostics, clinical presentations, treatment of the complications, preventive measures, including vaccination for a new coronavirus infection, are relevant. It is also important to identify risk factors for a severe course of the disease, features of the development of infection against the background of comorbid conditions and different immunological reactivity of the human body. The comorbidity of allergic and infectious diseases is based on the common humoral and cellular mechanisms of the immune response. The trigger for the development of allergic diseases is often the viruses of measles and chickenpox, influenza, parainfluenza, rhinoviruses, enteroviruses, respiratory syncytial viruses, coronaviruses, and others. Most allergic patients are predisposed to acute respiratory viral infections. COVID-19 occurs in 0.39–12.3% of children. Children tend to have milder disease than adults and have low mortality rates. At the same time, one should not forget about the adequate support for patients with chronic diseases, especially children with allergic diseases. Viruses and preventive hygiene measures associated with a pandemic are triggers of an exacerbation of bronchial asthma and atopic dermatitis. Early diagnosis, adequate treatment of allergic diseases in children, and provision of doctors with information are also problematic. It is important to understand which patients with bronchial asthma are at particular risk and how inhaled glucocorticosteroids may influence the course and outcome of COVID-19. International associations and societies have developed guidelines for the management of children with allergies during the COVID-19 pandemic. Inhaled glucocorticosteroids for bronchial asthma reduce the expression of genes of the main target receptors for the SARS-CoV-2 virus. Anti-inflammatory therapy for asthma, primarily inhaled glucocorticosteroids, should be continued until asthma control is achieved, which will help reduce the risk of an unfavorable course of COVID-19. |
| first_indexed | 2024-04-10T01:41:30Z |
| format | Article |
| id | doaj.art-90374fde2c134707a66c021e1e492859 |
| institution | Directory Open Access Journal |
| issn | 1027-4065 2500-2228 |
| language | Russian |
| last_indexed | 2024-04-10T01:41:30Z |
| publishDate | 2023-01-01 |
| publisher | Ltd. “The National Academy of Pediatric Science and Innovation” |
| record_format | Article |
| series | Rossijskij Vestnik Perinatologii i Pediatrii |
| spelling | doaj.art-90374fde2c134707a66c021e1e4928592023-03-13T09:12:53ZrusLtd. “The National Academy of Pediatric Science and Innovation”Rossijskij Vestnik Perinatologii i Pediatrii1027-40652500-22282023-01-01676253210.21508/1027-4065-2022-67-6-25-321274Allergic diseases in children in the age of the COVID-19 pandemicSh. A. Sulaimanov0Киргизско-российский славянский университет имени Бориса ЕльцынаCOVID-19 coronavirus infection caused by the SARS-CoV-2 virus has become a real disaster for all of humanity. Today, issues related to diagnostics, clinical presentations, treatment of the complications, preventive measures, including vaccination for a new coronavirus infection, are relevant. It is also important to identify risk factors for a severe course of the disease, features of the development of infection against the background of comorbid conditions and different immunological reactivity of the human body. The comorbidity of allergic and infectious diseases is based on the common humoral and cellular mechanisms of the immune response. The trigger for the development of allergic diseases is often the viruses of measles and chickenpox, influenza, parainfluenza, rhinoviruses, enteroviruses, respiratory syncytial viruses, coronaviruses, and others. Most allergic patients are predisposed to acute respiratory viral infections. COVID-19 occurs in 0.39–12.3% of children. Children tend to have milder disease than adults and have low mortality rates. At the same time, one should not forget about the adequate support for patients with chronic diseases, especially children with allergic diseases. Viruses and preventive hygiene measures associated with a pandemic are triggers of an exacerbation of bronchial asthma and atopic dermatitis. Early diagnosis, adequate treatment of allergic diseases in children, and provision of doctors with information are also problematic. It is important to understand which patients with bronchial asthma are at particular risk and how inhaled glucocorticosteroids may influence the course and outcome of COVID-19. International associations and societies have developed guidelines for the management of children with allergies during the COVID-19 pandemic. Inhaled glucocorticosteroids for bronchial asthma reduce the expression of genes of the main target receptors for the SARS-CoV-2 virus. Anti-inflammatory therapy for asthma, primarily inhaled glucocorticosteroids, should be continued until asthma control is achieved, which will help reduce the risk of an unfavorable course of COVID-19.https://www.ped-perinatology.ru/jour/article/view/1738детиcovid-19аллергиябронхиальная астмаатопический дерматитхроническая крапивница |
| spellingShingle | Sh. A. Sulaimanov Allergic diseases in children in the age of the COVID-19 pandemic Rossijskij Vestnik Perinatologii i Pediatrii дети covid-19 аллергия бронхиальная астма атопический дерматит хроническая крапивница |
| title | Allergic diseases in children in the age of the COVID-19 pandemic |
| title_full | Allergic diseases in children in the age of the COVID-19 pandemic |
| title_fullStr | Allergic diseases in children in the age of the COVID-19 pandemic |
| title_full_unstemmed | Allergic diseases in children in the age of the COVID-19 pandemic |
| title_short | Allergic diseases in children in the age of the COVID-19 pandemic |
| title_sort | allergic diseases in children in the age of the covid 19 pandemic |
| topic | дети covid-19 аллергия бронхиальная астма атопический дерматит хроническая крапивница |
| url | https://www.ped-perinatology.ru/jour/article/view/1738 |
| work_keys_str_mv | AT shasulaimanov allergicdiseasesinchildrenintheageofthecovid19pandemic |